Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. Nod™: The digital coach designed to help your baby sleep better
Nod Mom-Baby video capture

Nod™: The digital coach designed to help your baby sleep better

Is your little one keeping you up at night? This new app could help answer some of your late-night “I need more sleep!” prayers.

It’s a question that has mystified new parents since the dawn of time: “How in the world do I get this child to go to sleep?”
Thanks to novel 21st-century technology—and a partnership between Johnson & Johnson Consumer Inc. and Rest Devices, Inc., makers of the Mimo™ Baby Monitor—the answer (and those much-needed Zzzzs) could now be far less elusive.

It’s a collaboration that marries technology and expert coaching from JOHNSON’S® BEDTIME® Baby Sleep App with analytics from Mimo™'s infant sleep wearables and crib monitors to produce a new app called Nod™.

The goal: Both companies have studied hundreds of thousands of baby sleep patterns, so by combining their expertise, the Nod™ app can provide parents with an advanced, personalized sleep coaching system—like having a baby sleep expert in your own home.

The app debuts at the Consumer Electronics Show in Las Vegas this week. In anticipation, we tapped Russel Walters, Research Fellow of Biophysics and Modeling at Johnson & Johnson; sleep expert Jodi Mindell, Ph.D., CBSM ; and Dulcie Madden, Co-founder and CEO of Rest Devices, Inc., to walk us through the groundbreaking technology.

1775614113001-5270880003001-5270841823001-vs.jpg
nod_3_ƒ

More from Johnson & Johnson

6 ways Johnson & Johnson is using AI to help advance healthcare

Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.

How Johnson & Johnson is advancing the fight against Alzheimer’s disease

After decades of commitment to understanding this neurodegenerative disease, company scientists have developed innovative therapies and tools that can potentially slow its progression and ease the psychological toll on patients and caretakers. A cure is still elusive—but preventing the disease may be within reach.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.